Denisse Gardea-Gutiérrez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Denisse Gardea-Gutiérrez has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Berenice Erendira Oseguera-Guerra
Tecnologico de Monterrey, School of Engineering and Sciences, Av. H. Colegio Militar 4700, Nombre de Dios, Chihuahua 31300, Chih, Mexico
1 shared publication - Eduardo Núñez-García
Tecnologico de Monterrey, School of Engineering and Sciences, Av. H. Colegio Militar 4700, Nombre de Dios, Chihuahua 31300, Chih, Mexico
1 shared publication - Manuel Román-Aguirre
Centro de Investigación en Materiales Avanzados (CIMAV), Complejo Industrial Chihuahua, Miguel de Cervantes 120, Chihuahua 31136, Mexico
1 shared publication - Silvia Lorena Montes-Fonseca
Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Heroico Colegio Militar 4700, Col. Nombre de Dios, Chihuahua 31300, Mexico
1 shared publication
Latest Publications
- Open Access
- 23 May 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (6) , 777
Asymmetric Lipid Vesicles: Techniques, Applications, and Future Perspectives as an Innovative Drug Delivery System
Novel lipid-based nanosystems have been of interest in improving conventional drug release methods. Liposomes are the most studied nanostructures, consisting of lipid bilayers ideal for drug delivery, thanks to their resemblance to the cell plasma membrane. Asymmetric liposomes are vesicles with different lipids in their inner and outer layers; because of this, they can be configured to be compatible with the therapeutic drug while achieving biocompatibility and stability. Throughout this review, topics such as the applications, advantages, and synthesis techniques of asymmetric liposomes will be discussed. Further, an in silico analysis by computational tools will be examined as a helpful tool for designing and understanding asymmetric liposome mechanisms in pharmaceutical applications. The dual-engineered design of asymmetric liposomes makes them an ideal alternative for transdermal drug delivery because of the improved protection of pharmaceuticals without lowering adsorption rates and system biocompatibility.
- 23 May 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (6) , 777
Open AccessAsymmetric Lipid Vesicles: Techniques, Applications, and Future Perspectives as an Innovative Drug Delivery System
Novel lipid-based nanosystems have been of interest in improving conventional drug release methods. Liposomes are the most studied nanostructures, consisting of lipid bilayers ideal for drug delivery, thanks to their resemblance to the cell plasma membrane. Asymmetric liposomes are vesicles with different lipids in their inner and outer layers; because of this, they can be configured to be compatible with the therapeutic drug while achieving biocompatibility and stability. Throughout this review, topics such as the applications, advantages, and synthesis techniques of asymmetric liposomes will be discussed. Further, an in silico analysis by computational tools will be examined as a helpful tool for designing and understanding asymmetric liposome mechanisms in pharmaceutical applications. The dual-engineered design of asymmetric liposomes makes them an ideal alternative for transdermal drug delivery because of the improved protection of pharmaceuticals without lowering adsorption rates and system biocompatibility.